FDA Announces New Policies to Advance Cell and Gene Therapies
By EsqSocial Corporation 28/01/19
On Jan. 15, 2019, Food and Drug Administration (FDA) Commissioner Scott Gottlieb and Center for Biologics Evaluation and Research (CBER) Director Peter Marks issued a statement proposing policies to support cell and gene therapy product development....
By: Holland & Knight LLP